Neutrophil‐Lymphocyte Ratio May be Used as a Biomarker for Predicting Progression of Barrett's Esophagus to Esophageal Adenocarcinoma: A Retrospective Cohort Study
The study supports the potential use of NLR as a biomarker for predicting histologic progression in BE to EAC. The NLR could serve as a useful adjunct to current surveillance strategies to help guide clinical decision-making. Further research is necessary to validate these findings and determine the clinical utility of NLR as a predictor for dysplasia and neoplasia in BE patients.
Authors
- Janak Bahirwani (ORCID: https://orcid.org/0000-0002-9150-521X)
- Parampreet Kaur (ORCID: https://orcid.org/0000-0003-2264-634X)
- Zarian Prenatt (ORCID: https://orcid.org/0009-0002-5580-6717)
- Naomi Reddy‐Patel
- Yecheskel Schneider (ORCID: https://orcid.org/0000-0002-0680-3627)
- Het Patel (ORCID: https://orcid.org/0009-0007-9565-243X)
Institutions
- St. Luke's University Health Network (US)
Publication Details
- Journal
- JGH Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/jgh3.70115
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00